Retatrutide Monotherapy in Early Type 2 Diabetes: Glycemic Control and Weight Loss
Episode Summary
Retatrutide monotherapy substantially reduced A1C and body weight in early type 2 diabetes, highlighting triple-receptor agonism while leaving comparative effectiveness and long-term outcomes uncertain.